CAAS CAPITAL MANAGEMENT LP – Sarepta Therapeutics, Inc. Transaction History
CAAS CAPITAL MANAGEMENT LP portfolio value:
$4.75M
portfolio value
Sarepta Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | put | 0.00% | 0 shares | 3.27M | $110.54 | 92K | |
| Q3 2022 | call | 0.00% | 0 shares | 1.53M | $110.54 | 43K | |
| Q3 2022 | share | Decrease | -39.60% | -29.32K shares | -607K | $110.54 | 44.73K |
| Q2 2022 | put | 0.00% | 0 shares | -291K | $74.96 | 92K | |
| Q2 2022 | share | Increase | +12.55% | 8.26K shares | 412K | $74.96 | 74.06K |
| Q2 2022 | call | 0.00% | 0 shares | -136K | $74.96 | 43K | |
| Q1 2022 | put | Decrease | -35.66% | -51K shares | -5.69M | $78.12 | 92K |
| Q1 2022 | share | Decrease | -25.59% | -22.63K shares | -2.82M | $78.12 | 65.8K |
| Q1 2022 | call | Decrease | -40.28% | -29K shares | -3.12M | $78.12 | 43K |
| Q4 2021 | call | 0.00% | 0 shares | -175K | $90.59 | 72K | |
| Q4 2021 | put | 0.00% | 0 shares | -348K | $90.59 | 143K | |
| Q4 2021 | share | Increase | +7.26% | 5.98K shares | 339K | $90.59 | 88.43K |
| Q3 2021 | put | 0.00% | 0 shares | 2.10M | $92.48 | 143K | |
| Q3 2021 | share | Increase | +6.05% | 4.7K shares | 1.58M | $92.48 | 82.44K |
| Q3 2021 | call | 0.00% | 0 shares | 1.06M | $92.48 | 72K | |
| Q2 2021 | share | Increase | +45.38% | 24.26K shares | 2.05M | $77.74 | 77.74K |
| Q2 2021 | call | Increase | 0.00% | 72K shares | 5.59M | $77.74 | 72K |
| Q2 2021 | put | Increase | 0.00% | 143K shares | 11.11M | $77.74 | 143K |
| Q1 2021 | share | Increase | 0.00% | 53.47K shares | 3.98M | $74.53 | 53.47K |
| Q1 2021 | call | Decrease | -100.00% | -121.3K shares | -20.68M | $74.53 | 0 |
| Q1 2021 | put | Decrease | -100.00% | -121.7K shares | -20.74M | $74.53 | 0 |
| Q4 2020 | call | Increase | 0.00% | 121.3K shares | 20.68M | $170.49 | 121.3K |
| Q4 2020 | put | Increase | 0.00% | 121.7K shares | 20.74M | $170.49 | 121.7K |